Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...
The global COVID-19 pandemic highlighted the necessity of accelerating various stages of drug development, lowering drug candidate attrition rates, and establishing reliable testing processes to ...
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
The biopharmaceutical industry stands on the cusp of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of ...
The structure of a kinase enzyme inhibitor that could become a next-generation drug for melanoma made its public debut this week (Nature, DOI: 10.1038/nature09454). The unveiling comes on the heels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback